Publications by authors named "Jeffrey H Kordower"

100Publications

Reply to: "Toward a Personalized Approach to Parkinson's Cell Therapy".

Mov Disord 2020 Nov;35(11):2120-2121

Department of Neurology, Parkinson's Disease Center and Movement Disorders Clinic, Baylor College of Medicine, Houston, Texas, USA.

View Article and Find Full Text PDF
November 2020

Viral-based rodent and nonhuman primate models of multiple system atrophy: Fidelity to the human disease.

Neurobiol Dis 2021 Jan 19;148:105184. Epub 2020 Nov 19.

Department of Neurological Sciences, Rush University Medical Center, Chicago, IL 60612, USA. Electronic address:

View Article and Find Full Text PDF
January 2021

Inflammation in Experimental Models of α-Synucleinopathies.

Mov Disord 2020 Oct 3. Epub 2020 Oct 3.

Department of Radiology, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania, USA.

View Article and Find Full Text PDF
October 2020

Anti-α-synuclein ASO delivered to monoamine neurons prevents α-synuclein accumulation in a Parkinson's disease-like mouse model and in monkeys.

EBioMedicine 2020 Sep 15;59:102944. Epub 2020 Aug 15.

Institut d'Investigacions Biomèdiques de Barcelona (IIBB), Spanish National Research Council (CSIC), Barcelona, Spain; Institut d'Investigacions August Pi i Sunyer (IDIBAPS), Barcelona, Spain; Centro de Investigación Biomédica en Red de Salud Mental (CIBERSAM), ISCIII, Madrid, Spain. Electronic address:

View Article and Find Full Text PDF
September 2020

A Failed Future.

Mov Disord 2020 08;35(8):1299-1301

Department of Neurological Sciences, Rush University Medical Center, Chicago, Illinois, USA.

View Article and Find Full Text PDF
August 2020

Stem Cells: Scientific and Ethical Quandaries of a Personalized Approach to Parkinson's Disease.

Mov Disord 2020 08 7;35(8):1312-1314. Epub 2020 Jul 7.

Department of Neurological Sciences, Rush University Medical Center, Chicago, Illinois, USA.

View Article and Find Full Text PDF
August 2020

Long-term post-mortem studies following neurturin gene therapy in patients with advanced Parkinson's disease.

Brain 2020 03;143(3):960-975

Department of Neurological Sciences, Rush University Medical Center, Chicago, Illinois 60612, USA.

View Article and Find Full Text PDF
March 2020

Disease modification and biomarker development in Parkinson disease: Revision or reconstruction?

Neurology 2020 03 26;94(11):481-494. Epub 2020 Feb 26.

From the Department of Neurology (A.J.E.), James J. and Joan A. Gardner Family Center for Parkinson's Disease and Movement Disorders, University of Cincinnati, OH; Edmond J. Safra Program in Parkinson's Disease (L.V.K.), Krembil Research Institute, Toronto Western Hospital, Ontario, Canada; Department of Neurology and Neurosurgery (Z.G.-O.), Montreal Neurological Institute, and Department of Human Genetics (Z.G.-O.), McGill University, Montreal, Quebec, Canada; Department of Clinical Neurosciences (C.H.W.-G.), John van Geest Centre for Brain Repair, University of Cambridge, UK; Division of Medical Oncology and Hematology (P.L.B.), Princess Margaret Cancer Centre, University Health Network, and Department of Medicine (P.L.B.), University of Toronto, Ontario, Canada; Departments of Medicine (S.M.R.), Pediatrics (S.M.R.), Cell Developmental and Integrative Biology (S.M.R.), and Neurology (D.G.S.), University of Alabama at Birmingham; Department of Clinical and Experimental Medicine (F.M.), University of Messina, Italy; Institute of Molecular and Clinical Sciences (F.M.), St George's University of London, UK; Edmond J. Safra Program in Parkinson's Disease (A.F., A.P.S., A.E.L.), Morton and Gloria Shulman Movement Disorders Clinic, Toronto Western Hospital, University of Toronto; Krembil Research Institute (A.F., A.P.S., A.E.L.); Tomorrow Edition (B.S.), Toronto, Ontario, Canada; Consultorio y Laboratorio de Neurogenética (M.A.K.), Centro Universitario de Neurología "José María Ramos Mejía" y División Neurología, Hospital JM Ramos Mejía, Facultad de Medicina, UBA; Programa de Medicina de Precision y Genomica Clinica (M.A.K.), Instituto de Investigaciones en Medicina Traslacional, Facultad de Ciencias Biomédicas, Universidad Austral-CONICET, Buenos Aires, Argentina; Clinical Genomics Program (M.J.F.), Norman Fixel Institute for Neurological Diseases, McKnight Brain Institute, University of Florida Clinical and Translational Science Institute, Gainesville; Clinical Trials Statistical & Data Management Center (C.S.C.), University of Iowa College of Public Health, Iowa City; Department of Neurology (M.A.S.), Massachusetts General Hospital, Boston; Michael J. Fox Foundation for Parkinson's Research (T.S.), New York City, NY; Department of Neurology (R.B.P.), Montreal General Hospital, Quebec; Research Imaging Centre (A.P.S.), Campbell Family Mental Health Research Institute, Centre for Addiction and Mental Health, University of Toronto, Ontario, Canada; Laboratory of Neurogenetics (A.B.S.), National Institute on Aging, NIH, Bethesda, MD; Department of Clinical Neurosciences (R.A.B.), John van Geest Centre for Brain Repair, WT-MRC Cambridge Stem Cell Institute, University of Cambridge, UK; Clinical Trials Coordination Center (K.K.), University of Rochester Medical Center, NY; Department of Neurology and Neuroscience (C.W.O.), Mount Sinai School of Medicine, New York, NY; Clintrex LLC (C.W.O.), Sarasota, FL; Division of Neurosurgery (A.L.), Krembil Neuroscience Institute, Toronto Western Hospital, Ontario, Canada; Department of Neurological Sciences (J.H.K.), Rush University Medical Center, Chicago, IL; Coeruleus Clinical Sciences (J.M.C.), Woodbridge, CT; and Center for Neurodegenerative Science (P.B.), Van Andel Institute, Grand Rapids, MI.

View Article and Find Full Text PDF
March 2020

T cell infiltration in both human multiple system atrophy and a novel mouse model of the disease.

Acta Neuropathol 2020 05 29;139(5):855-874. Epub 2020 Jan 29.

Center for Neurodegeneration and Experimental Therapeutics, Department of Neurology, The University of Alabama at Birmingham (UAB), 1719 6th Ave. South, CIRC 446, Birmingham, AL, 35294-0021, USA.

View Article and Find Full Text PDF
May 2020

Endogenous alpha-synuclein monomers, oligomers and resulting pathology: let's talk about the lipids in the room.

NPJ Parkinsons Dis 2019 12;5:23. Epub 2019 Nov 12.

1Department of Neurological Sciences, Rush University Medical Center, Chicago, IL 60612 USA.

View Article and Find Full Text PDF
November 2019

Immunotherapy in Parkinson's disease: Current status and future directions.

Neurobiol Dis 2019 12 25;132:104587. Epub 2019 Aug 25.

Department of Neurological Sciences, Rush University Medical Center, Chicago, IL 60612, USA. Electronic address:

View Article and Find Full Text PDF
December 2019

Spreading of alpha-synuclein - relevant or epiphenomenon?

J Neurochem 2019 09 9;150(5):605-611. Epub 2019 Jul 9.

Department of Neurological Sciences, Rush University Medical Center, Chicago, Illinois, USA.

View Article and Find Full Text PDF
September 2019

Focused ultrasound opening of the blood-brain barrier for treatment of Parkinson's disease.

Mov Disord 2019 09 28;34(9):1274-1278. Epub 2019 May 28.

Department of Neurological Sciences, Rush University School of Medicine, Chicago, Illinois, USA.

View Article and Find Full Text PDF
September 2019

Temporal evolution of microglia and α-synuclein accumulation following foetal grafting in Parkinson's disease.

Brain 2019 06;142(6):1690-1700

Department of Neurological Sciences, Rush University Medical Center, Chicago Illinois, USA.

View Article and Find Full Text PDF
June 2019

Parkinson's disease gene therapy: Will focused ultrasound and nanovectors be the next frontier?

Mov Disord 2019 09 25;34(9):1279-1282. Epub 2019 Mar 25.

Department of Neurological Sciences, Rush University Medical Center, Chicago, Illinois, USA.

View Article and Find Full Text PDF
September 2019

Chronic stress-induced gut dysfunction exacerbates Parkinson's disease phenotype and pathology in a rotenone-induced mouse model of Parkinson's disease.

Neurobiol Dis 2020 02 21;135:104352. Epub 2018 Dec 21.

Department of Internal Medicine, Division of Digestive Diseases, Rush University Medical Center, Chicago, IL, USA; Division of Pharmacology, Utrecht Institute for Pharmaceutical Sciences, Utrecht University, Utrecht, Netherlands. Electronic address:

View Article and Find Full Text PDF
February 2020

Disease Modification Through Trophic Factor Delivery.

Methods Mol Biol 2018 ;1780:525-547

Department of Neurological Sciences, Rush University Medical Center, Chicago, IL, USA.

View Article and Find Full Text PDF
February 2019

Disease Modification for Parkinson's Disease: Axonal Regeneration and Trophic Factors.

Mov Disord 2018 05 30;33(5):678-683. Epub 2018 Mar 30.

Department of Neurology, Columbia University, New York, New York, USA.

View Article and Find Full Text PDF
May 2018

Analysis of age-related changes in psychosine metabolism in the human brain.

PLoS One 2018 26;13(2):e0193438. Epub 2018 Feb 26.

Department of Anatomy and Cell Biology, College of Medicine, University of Illinois at Chicago, Chicago, IL, United States of America.

View Article and Find Full Text PDF
May 2018

Do subjects with minimal motor features have prodromal Parkinson disease?

Ann Neurol 2018 03 10;83(3):562-574. Epub 2018 Mar 10.

Department of Neurological Sciences, Rush University Medical Center, Chicago, IL.

View Article and Find Full Text PDF
March 2018

Induction of alpha-synuclein pathology in the enteric nervous system of the rat and non-human primate results in gastrointestinal dysmotility and transient CNS pathology.

Neurobiol Dis 2018 04 16;112:106-118. Epub 2018 Jan 16.

Dept. of Neurological Science, Rush University Medical Center, Chicago, IL, United States; Center on Neurodegeneration, Van Andel Research Institute, Grand Rapids, MI, United States.

View Article and Find Full Text PDF
April 2018

Presence of tau pathology within foetal neural allografts in patients with Huntington's and Parkinson's disease.

Brain 2017 Nov;140(11):2982-2992

Centre de Recherche du CHU de Québec-Université Laval, Axe Neurosciences, 2705 Boulevard Laurier, Québec, QC, Canada.

View Article and Find Full Text PDF
November 2017

Therapeutic approaches to target alpha-synuclein pathology.

Exp Neurol 2017 12 4;298(Pt B):225-235. Epub 2017 Oct 4.

Center for Neurodegenerative Science, Van Andel Research Institute, Grand Rapids, MI 49503, USA; Department of Neurological Sciences, Rush University Medical Center, Chicago, IL 60612, USA.

View Article and Find Full Text PDF
December 2017

Novel oligodendroglial alpha synuclein viral vector models of multiple system atrophy: studies in rodents and nonhuman primates.

Acta Neuropathol Commun 2017 06 16;5(1):47. Epub 2017 Jun 16.

Department of Neurological Sciences, Rush University Medical Center, 1735 West Harrison Street, Chicago, IL, 60611, USA.

View Article and Find Full Text PDF
June 2017

Cryopreservation Maintains Functionality of Human iPSC Dopamine Neurons and Rescues Parkinsonian Phenotypes In Vivo.

Stem Cell Reports 2017 07 1;9(1):149-161. Epub 2017 Jun 1.

Department of Neurological Sciences, Rush University Medical Center, Chicago, IL 60612, USA; The Van Andel Institute, Grand Rapids, MI 49503, USA. Electronic address:

View Article and Find Full Text PDF
July 2017

Endocytic vesicle rupture is a conserved mechanism of cellular invasion by amyloid proteins.

Acta Neuropathol 2017 Oct 19;134(4):629-653. Epub 2017 May 19.

Integrative Cell Biology Program, Loyola University Chicago, Maywood, IL, 60153, USA.

View Article and Find Full Text PDF
October 2017

Aging and Parkinson's disease: Different sides of the same coin?

Mov Disord 2017 Jul 18;32(7):983-990. Epub 2017 May 18.

Department of Neurological Sciences, Rush University Medical Center, Chicago, Illinois, USA.

View Article and Find Full Text PDF
July 2017

α-Synuclein nonhuman primate models of Parkinson's disease.

J Neural Transm (Vienna) 2018 03 22;125(3):385-400. Epub 2017 Apr 22.

Department of Neurological Sciences, Rush University Medical Center, 1735 West Harrison St, Cohn Bldg Room 306, Chicago, IL, 60612, USA.

View Article and Find Full Text PDF
March 2018

What would Dr. James Parkinson think today? parcelling out the circuitry of levodopa-induced dyskinesias.

Mov Disord 2017 04;32(4):483-484

Department of Neurological Sciences, Rush University Medical Center, Chicago, Illinois, 60612.

View Article and Find Full Text PDF
April 2017

The Potential Role of Gut-Derived Inflammation in Multiple System Atrophy.

J Parkinsons Dis 2017 ;7(2):331-346

Department of Internal Medicine, Division of Gastroenterology, Rush University Medical Center, Chicago, IL, USA.

View Article and Find Full Text PDF
January 2018

Targeting α-Synuclein as a therapy for Parkinson's disease: The battle begins.

Mov Disord 2017 02;32(2):203-207

Department of Neurological Sciencs, Rush University Schoolf of Medicine, Chicago, Illinois, USA.

View Article and Find Full Text PDF
February 2017

Mechanisms for cell-to-cell propagation no longer lag behind.

Mov Disord 2016 12 22;31(12):1798-1799. Epub 2016 Nov 22.

Center for Neurodegenerative Science, Van Andel Research Institute, Grand Rapids, Michigan, USA.

View Article and Find Full Text PDF
December 2016

Parkinsonian monkeys with prior levodopa-induced dyskinesias followed by fetal dopamine precursor grafts do not display graft-induced dyskinesias.

J Comp Neurol 2017 02 29;525(3):498-512. Epub 2016 Aug 29.

Departments of Psychiatry and Neurosurgery, Yale University, New Haven, Connecticut, 06511.

View Article and Find Full Text PDF
February 2017

How strong is the evidence that Parkinson's disease is a prion disorder?

Curr Opin Neurol 2016 Aug;29(4):459-66

aTranslational Parkinson's Disease Research bPrion Mechanisms in Neurodegenerative Disease cParkinson's Disease: Pathogenesis and Experimental Therapeutics; Center for Neurodegenerative Science, Van Andel Research Institute, Grand Rapids, Michigan dDepartment of Neurological Sciences, Rush University Medical Center, Chicago, Illinois, USA.

View Article and Find Full Text PDF
August 2016

Fetal grafts for Parkinson's disease: Decades in the making.

Proc Natl Acad Sci U S A 2016 Jun 31;113(23):6332-4. Epub 2016 May 31.

Department of Neurology, Mt. Sinai School of Medicine, New York, NY 10029; Department of Neuroscience, Mt. Sinai School of Medicine, New York, NY 10029.

View Article and Find Full Text PDF
June 2016

Neutralization of RANTES and Eotaxin Prevents the Loss of Dopaminergic Neurons in a Mouse Model of Parkinson Disease.

J Biol Chem 2016 07 12;291(29):15267-81. Epub 2016 May 12.

From the Department of Neurological Sciences, Rush University Medical Center, Chicago, Illinois 60612

View Article and Find Full Text PDF
July 2016

TDP-43 Proteinopathy: Aggregation and Propagation in the Pathogenesis of Amyotrophic Lateral Sclerosis.

Mov Disord 2016 08 23;31(8):1139. Epub 2016 May 23.

Department of Neurological Sciences, Director, Research Center for Brain Repair, Section of Neuroscience, Rush University Medical Center, Chicago, Illinois, 60612.

View Article and Find Full Text PDF
August 2016

Alterations in Activity-Dependent Neuroprotective Protein in Sporadic and Experimental Parkinson's Disease.

J Parkinsons Dis 2016 ;6(1):77-97

Department of Neurological Sciences, Rush University Medical Center, Chicago, IL, USA.

View Article and Find Full Text PDF
January 2017

Preface.

Mov Disord 2016 Feb;31(2):151

Division of Clinical Neurobiology, Department of Neurology, Medical University, Innsbruck, Austria.

View Article and Find Full Text PDF
February 2016

Parkinson's disease and prion disease: Straining the comparison.

Mov Disord 2015 Nov;30(13):1727

Rush University Medical Center, Chicago, Illinois, USA.

View Article and Find Full Text PDF
November 2015

Trophic factors for Parkinson's disease: To live or let die.

Mov Disord 2015 Nov;30(13):1715-24

Rush University Medical Center, Chicago, Illinois, USA.

View Article and Find Full Text PDF
November 2015

AAV2-Neurturin for Parkinson's Disease: What Lessons Have We Learned?

Methods Mol Biol 2016 ;1382:485-90

Department of Neurological Sciences, Rush University Medical Center, Chicago, IL, 60612, USA.

View Article and Find Full Text PDF
October 2016

Broad distribution of ataxin 1 silencing in rhesus cerebella for spinocerebellar ataxia type 1 therapy.

Brain 2015 Dec 21;138(Pt 12):3555-66. Epub 2015 Oct 21.

4 The Raymond G Perelman Center for Cellular and Molecular Therapeutics, The Children's Hospital of Philadelphia, and the Department of Pathology and Laboratory Medicine, the University of Pennsylvania, Philadelphia, PA, USA

View Article and Find Full Text PDF
December 2015

Alpha-synuclein propagation: New insights from animal models.

Mov Disord 2016 Feb 8;31(2):161-8. Epub 2015 Sep 8.

Department of Neurological Sciences, The Graduate College, Rush University, Chicago, Illinois, USA.

View Article and Find Full Text PDF
February 2016

PGC-1α Promoter Methylation in Parkinson's Disease.

PLoS One 2015 28;10(8):e0134087. Epub 2015 Aug 28.

Department of Neuroscience, Georgetown University Medical Center, Washington DC, United States of America; Department of Neurology, Georgetown University Medical Center, Washington DC, United States of America.

View Article and Find Full Text PDF
May 2016

The native form of α-Synuclein: Monomer, tetramer, or a combination in equilibrium.

Mov Disord 2015 Dec 31;30(14):1870. Epub 2015 Jul 31.

Department of Neurological Sciences, Rush University Medical Center, Chicago, IL, USA.

View Article and Find Full Text PDF
December 2015

Analysis of YFP(J16)-R6/2 reporter mice and postmortem brains reveals early pathology and increased vulnerability of callosal axons in Huntington's disease.

Hum Mol Genet 2015 Sep 29;24(18):5285-98. Epub 2015 Jun 29.

Department of Anatomy and Cell Biology, University of Illinois at Chicago, 808 S. Wood St., Rm 578 M/C 512, Chicago, IL 60612, USA,

View Article and Find Full Text PDF
September 2015

The prion hypothesis of Parkinson's disease.

Curr Neurol Neurosci Rep 2015 May;15(5):28

Department of Neurological Sciences, Rush University Medical Center, 1735 West Harrison Street, Chicago, IL, 60612, USA,

View Article and Find Full Text PDF
May 2015

Gene therapy for Parkinson's disease: still a hot topic?

Neuropsychopharmacology 2015 Jan;40(1):255-6

Department of Neurological Sciences, Rush University Medical Center, Chicago, IL, USA.

View Article and Find Full Text PDF
January 2015

Peripheral alpha-synuclein and Parkinson's disease.

Mov Disord 2014 Jul;29(8):963-6

Departments of Neurology and Neuroscience, Mount Sinai School of Medicine, New York, NY, 10029, USA.

View Article and Find Full Text PDF
July 2014

Misfolded proteins in Huntington disease fetal grafts: further evidence of cell-to-cell transfer?

Ann Neurol 2014 Jul 9;76(1):20-1. Epub 2014 Jul 9.

Department of Neurological Sciences, Rush University Medical Center, Chicago, IL.

View Article and Find Full Text PDF
July 2014

Progression of intestinal permeability changes and alpha-synuclein expression in a mouse model of Parkinson's disease.

Mov Disord 2014 Jul 4;29(8):999-1009. Epub 2013 Nov 4.

Department of Neurosurgery, Rush University, Chicago, Illinois, USA; Department of Pharmacology, The Graduate College, Rush University, Chicago, Illinois, USA.

View Article and Find Full Text PDF
July 2014

The prion hypothesis of Parkinson's disease: this hot topic just got hotter.

Mov Disord 2014 Jul 27;29(8):988. Epub 2014 May 27.

Rush University Medical Center, Chicago, Illinois.

View Article and Find Full Text PDF
July 2014

Abnormal alpha-synuclein reduces nigral voltage-dependent anion channel 1 in sporadic and experimental Parkinson's disease.

Neurobiol Dis 2014 Sep 10;69:1-14. Epub 2014 May 10.

Department of Neurological Sciences, Rush University Medical Center, Chicago, IL 60612, USA. Electronic address:

View Article and Find Full Text PDF
September 2014

In memorium: Roy A.E. Bakay, MD.

Mov Disord 2013 Nov 21;28(13):1809-10. Epub 2013 Oct 21.

The Jean Schweppe-Armour Professor of Neurological Sciences, Professor of Neurosurgery, Director, Research Center for Brain Repair; Section Head, Neuroscience, Rush University Medical Center, Chicago, Illinois.

View Article and Find Full Text PDF
November 2013

Disease duration and the integrity of the nigrostriatal system in Parkinson's disease.

Brain 2013 Aug;136(Pt 8):2419-31

Department of Neurological Sciences, Rush University Medical Centre, Chicago, Illinois 60612, USA.

View Article and Find Full Text PDF
August 2013

Continuous DOPA synthesis from a single AAV: dosing and efficacy in models of Parkinson's disease.

Sci Rep 2013 ;3:2157

Brain Repair and Imaging in Neural Systems-B.R.A.I.N.S Unit, Department of Experimental Medical Science, Lund University, Lund, Sweden.

View Article and Find Full Text PDF
September 2013

Cell therapy for Parkinson's disease: what next?

Mov Disord 2013 Jan;28(1):110-5

Wallenberg Neuroscience Center, Lund University, Sweden.

View Article and Find Full Text PDF
January 2013

Trophic factor gene therapy for Parkinson's disease.

Mov Disord 2013 Jan;28(1):96-109

Department of Neurological Sciences, Rush University Medical Center, Chicago, Illinois 60612, USA.

View Article and Find Full Text PDF
January 2013

Neuropathology in transplants in Parkinson's disease: implications for disease pathogenesis and the future of cell therapy.

Prog Brain Res 2012 ;200:221-41

Van Andel Research Institute, Center for Neurodegenerative Science, Grand Rapids, MI, USA.

View Article and Find Full Text PDF
November 2013

Alterations in axonal transport motor proteins in sporadic and experimental Parkinson's disease.

Brain 2012 Jul 19;135(Pt 7):2058-73. Epub 2012 Jun 19.

Department of Neurological Sciences, Rush University Medical Centre, 1735 West Harrison Street, Chicago, IL 60612, USA.

View Article and Find Full Text PDF
July 2012

Testing NF-κB-based therapy in hemiparkinsonian monkeys.

J Neuroimmune Pharmacol 2012 Sep 3;7(3):544-56. Epub 2012 Jun 3.

Department of Neurological Sciences, Rush University Medical Center, 1735 West Harrison St, Suite 320, Chicago, IL 60612, USA.

View Article and Find Full Text PDF
September 2012

Is alpha-synuclein in the colon a biomarker for premotor Parkinson's disease? Evidence from 3 cases.

Mov Disord 2012 May 1;27(6):716-9. Epub 2012 May 1.

Department of Neurological Sciences, Rush Medical College, Chicago, Illinois 60612, USA.

View Article and Find Full Text PDF
May 2012

Gene therapy for Huntington's disease.

Neurobiol Dis 2012 Nov 24;48(2):243-54. Epub 2011 Dec 24.

Department of Neurological Sciences, Rush University Medical Center, Chicago, IL, USA.

View Article and Find Full Text PDF
November 2012

GDNF family ligands: a potential future for Parkinson's disease therapy.

CNS Neurol Disord Drug Targets 2011 Sep;10(6):703-11

Department of Neurological Sciences, Rush University Medical Center, Chicago, IL 60612, USA.

View Article and Find Full Text PDF
September 2011

Alpha-synuclein in colonic submucosa in early untreated Parkinson's disease.

Mov Disord 2012 May 15;27(6):709-15. Epub 2011 Jul 15.

Departments of Neurological Sciences, Rush Medical College, Chicago, Illinois 60612, USA.

View Article and Find Full Text PDF
May 2012

Transfer of host-derived α synuclein to grafted dopaminergic neurons in rat.

Neurobiol Dis 2011 Sep 12;43(3):552-7. Epub 2011 May 12.

Department of Neurological Sciences, Rush University Medical Center, Chicago, Illinois 60612, USA.

View Article and Find Full Text PDF
September 2011